Saad Mir, Weill Cornell, Department of Neurology Capstone overview:
The project is aimed at enhancing patient experience by improving communication with patients after they are discharged from the hospital. We are working on a new personalized text that is sent to the patient which links to medication education and videos, as well as creating a novel tele-pharmacy visit for patients who are discharged on new, high risk medications such as anticoagulation or insulin.
Project Name: Improving Post-Discharge Medication Education Using Texts and Tele-pharmacy
Mentor and Sponsor: Rick Evans, SVP, Chief Experience Officer
The goal of the project is to improve NYP’s patient experience performance in the domains of communication and medication teaching, as well as potentially reducing readmission by creating tele-pharmacy visits for patients taking high risk medications.
I have learned that there is a tremendous amount of innovation and collaboration at NYP.
Everyone has been extremely supportive and enthusiastic about succeeding in this project, which speaks volume about the culture at NYP to improve patient care. Rick Evans has helped me formulate the project concept, which entailed brainstorming on all the patient experience projects currently being done. Peter Fleischut helped catapult the project to the next level by mobilizing all the resources the project would need. I have been working closely with Sofia Fatalevich in the IT department on creating the medication education text. We are waiting for final procurement of Healthwise, which will be a tremendous patient education resource. Once this is complete, we hope to finalize the linking of medication education to patient’s medications which will ultimately be presented to patients in text form. I have also been working closely with the Innovation Team (Shauna Coyne, Graeme Ossey, Diana Kohlberg) and pharmacy (Leigh Effird) to create the tele-pharmacy work flow. We are working on using IT resources to identify patients being discharged on high risk medications. The technology component is close to implementation, and we are working to secure pharmacy resources to provide the tele-visit.
